{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T13:32:03Z","timestamp":1789651923045,"version":"4.0.0"},"reference-count":69,"publisher":"Elsevier BV","issue":"30","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31970178"],"award-info":[{"award-number":["31970178"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32000139"],"award-info":[{"award-number":["32000139"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32000140"],"award-info":[{"award-number":["32000140"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.vaccine.2023.05.074","type":"journal-article","created":{"date-parts":[[2023,6,10]],"date-time":"2023-06-10T10:28:12Z","timestamp":1686392892000},"page":"4402-4413","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Construction of an inhalable recombinant M2e-FP-expressing Bacillus subtilis spores-based vaccine and evaluation of its protection efficacy against influenza in a mouse model"],"prefix":"10.1016","volume":"41","author":[{"given":"Di","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengyuan","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingqing","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonghui","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolu","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingxiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"31","key":"10.1016\/j.vaccine.2023.05.074_b0005","doi-asserted-by":"crossref","first-page":"4291","DOI":"10.1016\/j.vaccine.2019.06.030","article-title":"An amphiphilic invertible polymer as a delivery vehicle for a M2e-HA2-HA1 peptide vaccine against an Influenza A virus in pigs","volume":"37","author":"Singh","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.05.074_b0010","doi-asserted-by":"crossref","first-page":"344","DOI":"10.3389\/fcimb.2019.00344","article-title":"The quest for a truly universal influenza vaccine","volume":"9","author":"Jang","year":"2019","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.vaccine.2023.05.074_b0015","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3390\/vaccines3010105","article-title":"M2e-based universal influenza A vaccines","volume":"3","author":"Deng","year":"2015","journal-title":"Vaccines"},{"key":"10.1016\/j.vaccine.2023.05.074_b0020","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1186\/1743-422X-7-351","article-title":"Conserved epitopes of influenza A virus inducing protective immunity and their prospects for universal vaccine development","volume":"7","author":"Stanekov\u00e1","year":"2010","journal-title":"Virol J"},{"issue":"48","key":"10.1016\/j.vaccine.2023.05.074_b0025","doi-asserted-by":"crossref","first-page":"6068","DOI":"10.1016\/j.vaccine.2008.09.015","article-title":"Universal antibodies and their applications to the quantitative determination of virtually all subtypes of the influenza A viral hemagglutinins","volume":"26","author":"Chun","year":"2008","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2023.05.074_b0030","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.micinf.2010.01.001","article-title":"Research and development of universal influenza vaccines","volume":"12","author":"Du","year":"2010","journal-title":"Microbes Infect"},{"issue":"7","key":"10.1016\/j.vaccine.2023.05.074_b0035","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1007\/s10529-020-02822-3","article-title":"An approach to the influenza chimeric subunit vaccine (3M2e-HA2-NP) provides efficient protection against lethal virus challenge","volume":"42","author":"Saleh","year":"2020","journal-title":"Biotechnol Lett"},{"key":"10.1016\/j.vaccine.2023.05.074_b0040","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/0092-8674(85)90157-6","article-title":"Fusion mutants of the influenza virus hemagglutinin glycoprotein","volume":"40","author":"Daniels","year":"1985","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.vaccine.2023.05.074_b0045","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.micinf.2017.08.010","article-title":"Highly conserved M2e and hemagglutinin epitope-based recombinant proteins induce protection against influenza virus infection","volume":"19","author":"Guo","year":"2017","journal-title":"Microbes Infect"},{"issue":"12","key":"10.1016\/j.vaccine.2023.05.074_b0050","doi-asserted-by":"crossref","first-page":"3649","DOI":"10.4161\/hv.36122","article-title":"Development of a heat-stable and orally delivered recombinant M2e-expressing B. subtilis spore-based influenza vaccine","volume":"10","author":"Zhao","year":"2014","journal-title":"Hum Vaccin Immunother"},{"issue":"4","key":"10.1016\/j.vaccine.2023.05.074_b0055","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1586\/erv.09.6","article-title":"Universal M2 ectodomain-based influenza A vaccines: preclinical and clinical developments","volume":"8","author":"Schotsaert","year":"2009","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2023.05.074_b0060","doi-asserted-by":"crossref","first-page":"169","DOI":"10.4149\/av_2012_03_169","article-title":"Two distinct regions of HA2 glycopolypeptide of influenza virus hemagglutinin elicit cross-protective immunity against influenza","volume":"56","author":"Janul\u00edkov\u00e1","year":"2012","journal-title":"Acta Virol"},{"issue":"1-2","key":"10.1016\/j.vaccine.2023.05.074_b0065","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jviromet.2013.08.022","article-title":"The highly conserved HA2 protein of the influenza A virus induces a cross protective immune response","volume":"194","author":"Lee","year":"2013","journal-title":"J Virol Methods"},{"key":"10.1016\/j.vaccine.2023.05.074_b0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0014442","article-title":"Immunopotentiation of trivalent influenza vaccine when given with VAX102, a recombinant influenza M2e vaccine fused to the TLR5 ligand flagellin","volume":"5","author":"Talbot","year":"2010","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.vaccine.2023.05.074_b0075","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S1473-3099(19)30393-7","article-title":"Immunogenicity of chimeric haemagglutinin-based, universal influenza virus vaccine candidates: interim results of a randomised, placebo-controlled, phase 1 clinical trial","volume":"20","author":"Bernstein","year":"2020","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2023.05.074_b0080","doi-asserted-by":"crossref","DOI":"10.1128\/Spectrum.00687-21","article-title":"Development of an inactivated H7N9 subtype avian influenza serological DIVA vaccine using the chimeric HA epitope approach","volume":"9","author":"Sun","year":"2021","journal-title":"Microbiol Spectr"},{"issue":"9","key":"10.1016\/j.vaccine.2023.05.074_b0085","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.3390\/v12091033","article-title":"Progress in the development of universal influenza vaccines","volume":"12","author":"Sun","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2023.05.074_b0090","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.femsre.2004.12.001","article-title":"The use of bacterial spore formers as probiotics","volume":"29","author":"Hong","year":"2005","journal-title":"FEMS Microbiol Rev"},{"issue":"4","key":"10.1016\/j.vaccine.2023.05.074_b0095","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1007\/s00253-019-10316-0","article-title":"Oral delivery of Bacillus subtilis spores expressing Clonorchis sinensis paramyosin protects grass carp from cercaria infection","volume":"104","author":"Sun","year":"2020","journal-title":"Appl Microbiol Biotechnol"},{"key":"10.1016\/j.vaccine.2023.05.074_b0100","article-title":"Surface display of antigen protein VP8* of porcine rotavirus on spores using CotB as a fusion partner","volume":"24","author":"Li","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.vaccine.2023.05.074_b0105","first-page":"1135","article-title":"Bacillus subtilis comes of age as a vaccine production host and delivery vehicle","volume":"14","author":"Rosales-Mendoza","year":"2015","journal-title":"Expert Rev Vaccines"},{"issue":"2","key":"10.1016\/j.vaccine.2023.05.074_b0110","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1128\/IAI.71.2.801-813.2003","article-title":"Use of a promoter trap system in Bacillus anthracis and Bacillus subtilis for the development of recombinant protective antigen-based vaccines","volume":"71","author":"Gat","year":"2003","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2023.05.074_b0115","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1128\/IAI.01255-13","article-title":"Gut adhesive Bacillus subtilis spores as a platform for mucosal delivery of antigens","volume":"82","author":"Tavares Batista","year":"2014","journal-title":"Infect Immun"},{"issue":"21","key":"10.1016\/j.vaccine.2023.05.074_b0120","doi-asserted-by":"crossref","first-page":"6294","DOI":"10.1128\/JB.183.21.6294-6301.2001","article-title":"Surface display of recombinant proteins on Bacillus subtilis spores","volume":"183","author":"Isticato","year":"2001","journal-title":"J Bacteriol"},{"issue":"7","key":"10.1016\/j.vaccine.2023.05.074_b0125","doi-asserted-by":"crossref","first-page":"979","DOI":"10.4161\/hv.20694","article-title":"Bacillus subtilis: a temperature resistant and needle free delivery system of immunogens","volume":"8","author":"Amuguni","year":"2012","journal-title":"Hum Vaccin Immunother"},{"issue":"3","key":"10.1016\/j.vaccine.2023.05.074_b0130","doi-asserted-by":"crossref","DOI":"10.1128\/AEM.02334-17","article-title":"Biological containment of genetically modified Bacillus subtilis","volume":"84","author":"Hosseini","year":"2018","journal-title":"Appl Environ Microbiol"},{"issue":"41","key":"10.1016\/j.vaccine.2023.05.074_b0135","doi-asserted-by":"crossref","first-page":"6658","DOI":"10.1016\/j.vaccine.2010.08.016","article-title":"Efficacy, heat stability and safety of intranasally administered Bacillus subtilis spore or vegetative cell vaccines expressing tetanus toxin fragment C","volume":"28","author":"Lee","year":"2010","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2023.05.074_b0140","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1002\/eji.200636875","article-title":"Bacillus subtilis spores: a novel microparticle adjuvant which can instruct a balanced Th1 and Th2 immune response to specific antigen","volume":"37","author":"Barnes","year":"2007","journal-title":"Eur J Immunol"},{"issue":"15","key":"10.1016\/j.vaccine.2023.05.074_b0145","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1016\/j.vaccine.2008.02.015","article-title":"Oral administration of a Bacillus subtilis spore-based vaccine expressing Clonorchis sinensis tegumental protein 22.3 kDa confers protection against Clonorchis sinensis","volume":"26","author":"Zhou","year":"2008","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2023.05.074_b0150","doi-asserted-by":"crossref","first-page":"5257","DOI":"10.1128\/IAI.00686-08","article-title":"Recombinant Bacillus subtilis expressing the Clostridium perfringens alpha toxoid is a candidate orally delivered vaccine against necrotic enteritis","volume":"76","author":"Hoang","year":"2008","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2023.05.074_b0155","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/s13568-020-01152-x","article-title":"Oral administration of recombinant Bacillus subtilis spores expressing mutant staphylococcal enterotoxin B provides potent protection against lethal enterotoxin challenge","volume":"10","author":"Xiong","year":"2020","journal-title":"AMB Express"},{"issue":"S4","key":"10.1016\/j.vaccine.2023.05.074_b0160","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1038\/nm1213","article-title":"Mucosal immunity and vaccines","volume":"11","author":"Holmgren","year":"2005","journal-title":"Nat Med"},{"issue":"10","key":"10.1016\/j.vaccine.2023.05.074_b0165","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S1473-3099(10)70157-2","article-title":"Needle-free influenza vaccination","volume":"10","author":"Amorij","year":"2010","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2023.05.074_b0170","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jconrel.2010.02.025","article-title":"A comparison between spray drying and spray freeze drying to produce an influenza subunit vaccine powder for inhalation","volume":"144","author":"Saluja","year":"2010","journal-title":"J Control Release"},{"key":"10.1016\/j.vaccine.2023.05.074_b0175","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jconrel.2013.11.013","article-title":"Evaluation of monophosphoryl lipid A as adjuvant for pulmonary delivered influenza vaccine","volume":"174","author":"Patil","year":"2014","journal-title":"J Control Release"},{"issue":"3","key":"10.1016\/j.vaccine.2023.05.074_b0180","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.chom.2015.02.012","article-title":"Influenza vaccines: challenges and solutions","volume":"17","author":"Houser","year":"2015","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.vaccine.2023.05.074_b0185","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.addr.2015.03.007","article-title":"Delivery strategies to enhance oral vaccination against enteric infections","volume":"91","author":"Davitt","year":"2015","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.vaccine.2023.05.074_b0190","doi-asserted-by":"crossref","first-page":"378","DOI":"10.3390\/pharmaceutics6030378","article-title":"Intranasal DNA vaccine for protection against respiratory infectious diseases: The delivery perspectives","volume":"6","author":"Xu","year":"2014","journal-title":"Pharmaceutics"},{"issue":"4","key":"10.1016\/j.vaccine.2023.05.074_b0195","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.2353\/ajpath.2010.090949","article-title":"Seasonal and pandemic human influenza viruses attach better to human upper respiratory tract epithelium than avian influenza viruses","volume":"176","author":"van Riel","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1016\/j.vaccine.2023.05.074_b0200","doi-asserted-by":"crossref","first-page":"4457","DOI":"10.2147\/IDR.S326230","article-title":"Evaluation of phage therapy for pulmonary infection of mouse by liquid aerosol-exposure Pseudomonas aeruginosa","volume":"14","author":"Zhang","year":"2021","journal-title":"Infect Drug Resist"},{"issue":"44","key":"10.1016\/j.vaccine.2023.05.074_b0205","doi-asserted-by":"crossref","first-page":"7233","DOI":"10.1016\/j.vaccine.2010.08.049","article-title":"Induction of protection against divergent H5N1 influenza viruses using a recombinant fusion protein linking influenza M2e to Onchocerca volvulus activation associated protein-1 (ASP-1) adjuvant","volume":"28","author":"Zhao","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.05.074_b0210","series-title":"Molecular Medical Microbiology","first-page":"199","article-title":"10 - Spores, Sporulation and Germination","author":"Prajapati","year":"2002"},{"key":"10.1016\/j.vaccine.2023.05.074_b0215","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1010660","article-title":"A protein-protein interaction map reveals that the Coxiella burnetii effector CirB inhibits host proteasome activity","volume":"18","author":"Fu","year":"2022","journal-title":"PLoS pathogens"},{"issue":"41","key":"10.1016\/j.vaccine.2023.05.074_b0220","doi-asserted-by":"crossref","first-page":"6076","DOI":"10.1016\/j.vaccine.2019.08.041","article-title":"Enhanced protection against Q fever in BALB\/c mice elicited by immunization of chloroform-methanol residue of Coxiella burnetii via intratracheal inoculation","volume":"37","author":"Feng","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.05.074_b0225","doi-asserted-by":"crossref","first-page":"473","DOI":"10.3389\/fcimb.2020.00473","article-title":"Construction of a live-attenuated vaccine strain of Yersinia pestis EV76-B-SHU\u0394pla and evaluation of its protection efficacy in a mouse model by aerosolized intratracheal inoculation","volume":"10","author":"Feng","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.vaccine.2023.05.074_b0230","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0087206","article-title":"Exploratory study on Th1 epitope-induced protective immunity against Coxiella burnetii infection","volume":"9","author":"Xiong","year":"2014","journal-title":"PLoS One."},{"key":"10.1016\/j.vaccine.2023.05.074_b0235","series-title":"WHO manual on animal influenza diagnosis and surveillance","author":"World Health O","year":"2002"},{"key":"10.1016\/j.vaccine.2023.05.074_b0240","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3389\/fimmu.2018.00116","article-title":"Pan-Influenza A protection by prime-boost vaccination with cold-adapted live-attenuated influenza vaccine in a mouse model","volume":"9","author":"Jang","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2023.05.074_b0245","first-page":"71","article-title":"An improvement of the 2\u0302(-delta delta CT) method for quantitative real-time polymerase chain reaction data analysis","volume":"3","author":"Rao","year":"2013","journal-title":"Biostat Bioinforma Biomath"},{"issue":"3","key":"10.1016\/j.vaccine.2023.05.074_b0250","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ejpb.2005.04.009","article-title":"Non-invasive pulmonary aerosol delivery in mice by the endotracheal route","volume":"61","author":"Bivasbenita","year":"2005","journal-title":"Eur J Pharm Biopharm"},{"issue":"1","key":"10.1016\/j.vaccine.2023.05.074_b0255","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/s41541-021-00349-w","article-title":"Intratracheal inoculation of AHc vaccine induces protection against aerosolized botulinum neurotoxin A challenge in mice","volume":"6","author":"Gan","year":"2021","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.vaccine.2023.05.074_b0260","article-title":"Aerosolized intratracheal inoculation of recombinant protective antigen (rPA) vaccine provides protection against inhalational anthrax in B10.D2-Hc Mice","volume":"13","author":"Song","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2023.05.074_b0265","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.3389\/fimmu.2019.01605","article-title":"Innovative mucosal vaccine formulations against influenza A virus infections","volume":"10","author":"Calzas","year":"2019","journal-title":"Front Immunol"},{"issue":"8","key":"10.1016\/j.vaccine.2023.05.074_b0270","doi-asserted-by":"crossref","first-page":"862","DOI":"10.3390\/v12080862","article-title":"Emerging role of mucosal vaccine in preventing infection with avian influenza A viruses","volume":"12","author":"Wang","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2023.05.074_b0275","first-page":"381","article-title":"B cell responses to influenza infection and vaccination","volume":"386","author":"Chiu","year":"2015","journal-title":"Curr Top Microbiol Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2023.05.074_b0280","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1128\/IAI.71.1.465-473.2003","article-title":"Differential cytokine pattern in the spleens and livers of BALB\/c mice infected with Penicillium marneffei: protective role of gamma interferon","volume":"71","author":"Sisto","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2023.05.074_b0285","doi-asserted-by":"crossref","first-page":"4976","DOI":"10.4049\/jimmunol.169.9.4976","article-title":"Long-term maintenance of virus-specific effector memory CD8+ T cells in the lung airways depends on proliferation","volume":"169","author":"Hogan","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2023.05.074_b0290","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3201\/eid1201.051237","article-title":"Cell-mediated protection in influenza infection","volume":"12","author":"Thomas","year":"2006","journal-title":"Emerg Infect Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2023.05.074_b0295","doi-asserted-by":"crossref","first-page":"L650","DOI":"10.1152\/ajplung.00360.2014","article-title":"Inflammatory impact of IFN-\u03b3 in CD8+ T cell-mediated lung injury is mediated by both Stat1-dependent and -independent pathways","volume":"308","author":"Ramana","year":"2015","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.vaccine.2023.05.074_b0300","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00745-21","article-title":"Therapy with M2e-specific IgG selects for an influenza A virus mutant with delayed matrix protein 2 expression","volume":"12","author":"Van den Hoecke","year":"2021","journal-title":"mBio"},{"key":"10.1016\/j.vaccine.2023.05.074_b0305","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nri2206","article-title":"Fcgamma receptors as regulators of immune responses","volume":"8","author":"Nimmerjahn","year":"2008","journal-title":"Nat Rev Immunol"},{"issue":"50","key":"10.1016\/j.vaccine.2023.05.074_b0310","doi-asserted-by":"crossref","first-page":"7026","DOI":"10.1016\/j.vaccine.2017.10.051","article-title":"Development of a novel dual-domain nanoparticle antigen construct for universal influenza vaccine","volume":"35","author":"Ni","year":"2017","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2023.05.074_b0315","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.antiviral.2012.09.008","article-title":"Heterosubtypic protection against influenza A induced by adenylate cyclase toxoids delivering conserved HA2 subunit of hemagglutinin","volume":"97","author":"Stanekov\u00e1","year":"2013","journal-title":"Antiviral Res"},{"key":"10.1016\/j.vaccine.2023.05.074_b0320","doi-asserted-by":"crossref","first-page":"7381","DOI":"10.4049\/jimmunol.166.12.7381","article-title":"Fc receptor-mediated phagocytosis makes a significant contribution to clearance of influenza virus infections","volume":"166","author":"Huber","year":"2001","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2023.05.074_b0325","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nm.3443","article-title":"Broadly neutralizing hemagglutinin stalk-specific antibodies require Fc\u03b3R interactions for protection against influenza virus in vivo","volume":"20","author":"DiLillo","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2023.05.074_b0330","doi-asserted-by":"crossref","first-page":"22","DOI":"10.32607\/20758251-2019-11-4-22-32","article-title":"Non-neutralizing antibodies directed at conservative influenza antigens","volume":"11","author":"Sedova","year":"2019","journal-title":"Acta Nat"},{"key":"10.1016\/j.vaccine.2023.05.074_b0335","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.coviro.2016.12.002","article-title":"Antibody-dependent cellular cytotoxicity and influenza virus","volume":"22","author":"Vanderven","year":"2017","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.vaccine.2023.05.074_b0340","doi-asserted-by":"crossref","first-page":"213","DOI":"10.4110\/in.2015.15.5.213","article-title":"Mechanisms of Cross-protection by Influenza Virus M2-based Vaccines","volume":"15","author":"Lee","year":"2015","journal-title":"Immune Netw"},{"issue":"1","key":"10.1016\/j.vaccine.2023.05.074_b0345","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.imlet.2006.04.014","article-title":"In search of the elusive mouse macrophage Fc-alpha receptor","volume":"107","author":"Reljic","year":"2006","journal-title":"Immunol Lett"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23006552?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23006552?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:28:08Z","timestamp":1759404488000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X23006552"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":69,"journal-issue":{"issue":"30","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S0264410X23006552"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.05.074","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Construction of an inhalable recombinant M2e-FP-expressing Bacillus subtilis spores-based vaccine and evaluation of its protection efficacy against influenza in a mouse model","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.05.074","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}